Lv33
236 积分 2026-02-07 加入
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
9小时前
待确认
Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial
21小时前
已完结
MRI-PDFF≥70% Reduction Was Associated With Fibrosis Improvement With Tirzepatide: Post-Hoc Analysis of the SYNERGY-NASH Phase 2B Trial
2天前
求助中
A reasonably likely surrogate endpoint for metabolic dysfunction–associated steatohepatitis
19天前
已完结
The G Protein-Coupled Bile Acid Receptor, TGR5, Stimulates Gallbladder Filling
28天前
已完结
Comparing the Intestinotrophic Effects of 2 Glucagon‐Like Peptide‐2 Analogues in the Treatment of Short‐Bowel Syndrome in Neonatal Piglets
29天前
已完结
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
1个月前
已完结
HM15912, a Novel Long-Acting Glucagon-Like Peptide-2 Analog, Improves Intestinal Growth and Absorption Capacity in a Male Rat Model of Short Bowel Syndrome
1个月前
已完结
Therapeutic potential of T akeda‐ G ‐protein‐receptor‐5 ( TGR5 ) agonists. H ope or hype?
1个月前
已完结
Teduglutide for treating short-bowel syndrome in adults: a meta-analysis of real-world evidence compared to clinical trial data
1个月前
已完结
皖公网安备34019202002308
